Clinical Evidence

Building Evidence for Longitudinal Cardiac Imaging

Sonologi is evaluating its wearable ultrasound and AI platform in clinical environments to understand its ability to capture and interpret cardiac information over time.

The company’s clinical development strategy begins with high-acuity cardiac settings, where changes in patient condition can occur between conventional examinations.

Early Testing in ICU Patients

Tested in more than 10 ICU patients.

Sonologi’s wearable ultrasound technology has undergone early testing in more than 10 intensive care unit patients.

This work has been used to evaluate the feasibility of wearable cardiac imaging in a real clinical environment and to inform the continued development of the device, imaging workflow and analysis platform.

These findings represent early-stage clinical and technical evaluation. They should not be interpreted as evidence of commercial availability, regulatory clearance or definitive clinical efficacy.

AI-Based Cardiac Pressure Estimation

5.6 mmHg reported error in a small held-out cohort.

Early model development has explored whether ultrasound imaging information can be used to estimate clinically relevant cardiac measurements.

In a small held-out cohort of 47 patients, the model reported an error of 5.6 mmHg for the evaluated pressure-estimation task.

The reported cohort was limited primarily to patients with heart failure with reduced ejection fraction, or HFrEF, defined in the study context as LVEF of 40% or below.

The result was obtained from a small held-out research cohort and requires validation in larger, more diverse and prospective patient populations.

What Sonologi Is Evaluating

Wearability

Can cardiac ultrasound data be captured through a wearable system in real clinical settings?

Imaging Continuity

Can the platform maintain useful cardiac imaging information over an extended observation period?

AI Interpretation

Can AI identify measurements, patterns and trends within longitudinal ultrasound data?

Clinical Utility

Can longitudinal imaging provide clinicians with information that is not available from isolated examinations alone?

Initial Clinical Settings

Sonologi’s early clinical strategy focuses on settings where patients face elevated risk and where intermittent assessments may leave important changes unobserved.

High-Acuity Care

Continuous or repeated imaging may provide additional visibility into cardiac changes in closely monitored patients.

Heart Failure Management

Longitudinal imaging may help clinicians understand how cardiac function changes during treatment, recovery and disease progression.

Post-Discharge Monitoring

The period after hospital discharge is a vulnerable time for many heart failure patients. Sonologi is exploring how continuous imaging could extend cardiac visibility beyond the hospital.

Clinical Development Path

Sonologi is advancing the platform through a staged development process that includes system refinement, clinical validation, regulatory preparation and future hospital deployment.

1. Wearable ultrasound system development

2. Technical and workflow testing

3. Evaluation in high-acuity clinical settings

4. Expanded clinical validation

5. Regulatory development

6. Initial hospital implementation

A Research-Driven Development Process

Sonologi is committed to building clinical evidence carefully and transparently.

Current findings are preliminary and remain subject to continued technical testing, clinical validation and applicable regulatory review. Additional information will be published as studies progress and results become available for public release.

Read the Science Behind the Platform

View Publications

/new-page-2